Robinhood Crypto Futures May Launch in the US and Europe Soon to Boost Markets
Key Points:
- Robinhood crypto futures is planned for launch in the US and Europe, using licenses from its Bitstamp acquisition.
- Despite regulatory challenges, Robinhood is expanding crypto services across all US states.
- Robinhood aims to introduce CME-based futures for Bitcoin and Ether, focusing on global expansion and product diversification.
Robinhood crypto futures trading is reportedly introduced in both the US and Europe in the coming months.
Robinhood Crypto Futures Looks for Expansion in US and Europe
According to sources familiar with the matter cited by Bloomberg, the platform is leveraging licenses acquired through its $200 million acquisition of Bitstamp, a crypto exchange.
The firm intends to utilize these licenses to offer perpetual futures contracts for Bitcoin and other digital assets. Robinhood crypto futures trading expansion marks its strategic expansion into futures trading, building on its recent initiatives despite regulatory challenges.
Earlier this year, Robinhood, the popular commission-free trading app, received a Wells Notice from the US Securities and Exchange Commission (SEC) regarding tokens traded on its platform. However, this hasn’t deterred the company from advancing its crypto strategy. In addition to the Bitstamp acquisition, Robinhood has also secured a futures broker license from Marex, enabling it to pursue futures offerings in the US market.
Robinhood Crypto Enhances Growth in the US and Globally
In May, Robinhood Crypto reported significant earnings, driven by robust trading activity. Despite a subsequent drop in crypto trading volume from $10.1 billion in April to $7.1 billion, the platform continues to expand its services. Recently, it expanded trading services across all 50 US states, offering 15 assets including Bitcoin, Ethereum, Dogecoin, and Avalanche.
Looking ahead, Robinhood aims to further enhance its market presence through the launch of CME-based futures for Bitcoin and Ether, pending regulatory approvals.
DISCLAIMER: The information on this website is provided as general market commentary and does not constitute investment advice. We encourage you to do your own research before investing. |